Optimisation of the 10-23 DNAzyme-substrate pairing interactions enhanced RNA cleavage activity at purine-cytosine target sites

被引:107
作者
Cairns, MJ [1 ]
King, A [1 ]
Sun, LQ [1 ]
机构
[1] Johnson & Johnson Res Labs, Eveleigh, NSW 1430, Australia
关键词
D O I
10.1093/nar/gkg378
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 10-23 RNA cleaving DNAzyme has been shown to cleave any purine-pyrimidine (RY) junction under simulated physiological conditions. In this study, we systematically examine the DNAzymes relative activity against different RY combinations in order to determine the hierarchy of substrate core dinucleotide sequence susceptibility. The reactivity of each substrate dinucleotide compared in the same background sequence with the appropriately matched DNAzyme was found to follow the scheme AU=GUgreater than or equal toGC>>AC. The relatively poor activity of the DNAzyme against AC and GC containing substrates was found to be improved substantially by modifications to the binding domain which subtly weaken its interaction with the substrate core. The most effective modification resulting in rate enhancement of up to 200-fold, was achieved by substitution of deoxyguanine with deoxyinosine such that the base pair interaction with the RNA substrates core C is reduced from three hydrogen bonds to two. The increased cleavage activity generated by this modification could be important for application of the 10-23 DNAzyme particularly when the target site core is an AC dinucleotide.
引用
收藏
页码:2883 / 2889
页数:7
相关论文
共 16 条
[1]   The use of diaminopurine to investigate structural properties of nucleic acids and molecular recognition between ligands and DNA [J].
Bailly, C ;
Waring, MJ .
NUCLEIC ACIDS RESEARCH, 1998, 26 (19) :4309-4314
[2]  
Cairns M J, 2000, Nucleic Acids Res, V28, pE9, DOI 10.1093/nar/28.3.e9
[3]   The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzyme [J].
Cairns, MJ ;
Hopkins, TM ;
Witherington, C ;
Sun, LQ .
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2000, 10 (05) :323-332
[4]   Target site selection for an RNA-cleaving catalytic DNA [J].
Cairns, MJ ;
Hopkins, TM ;
Witherington, C ;
Wang, L ;
Sun, LQ .
NATURE BIOTECHNOLOGY, 1999, 17 (05) :480-486
[5]   RNA CATALYTIC PROPERTIES OF THE MINIMUM (-)STRSV SEQUENCE [J].
HAMPEL, A ;
TRITZ, R .
BIOCHEMISTRY, 1989, 28 (12) :4929-4933
[6]   SIMPLE RNA ENZYMES WITH NEW AND HIGHLY SPECIFIC ENDORIBONUCLEASE ACTIVITIES [J].
HASELOFF, J ;
GERLACH, WL .
NATURE, 1988, 334 (6183) :585-591
[7]   Unexpected anisotropy in substrate cleavage rates by asymmetric hammerhead ribozymes [J].
Hendry, P ;
McCall, M .
NUCLEIC ACIDS RESEARCH, 1996, 24 (14) :2679-2684
[8]   Extending the cleavage rules for the hammerhead ribozyme:: mutating adenosine15.1 to inosine15.1 changes the cleavage site specificity from N16.2U16.1H17 to N16.2C16.1H17 [J].
Ludwig, J ;
Blaschke, M ;
Sproat, BS .
NUCLEIC ACIDS RESEARCH, 1998, 26 (10) :2279-2285
[9]   OLIGORIBONUCLEOTIDE SYNTHESIS USING T7 RNA-POLYMERASE AND SYNTHETIC DNA TEMPLATES [J].
MILLIGAN, JF ;
GROEBE, DR ;
WITHERELL, GW ;
UHLENBECK, OC .
NUCLEIC ACIDS RESEARCH, 1987, 15 (21) :8783-8798
[10]   New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury [J].
Santiago, FS ;
Lowe, HC ;
Kavurma, MM ;
Chesterman, CN ;
Baker, A ;
Atkins, DG ;
Khachigian, LM .
NATURE MEDICINE, 1999, 5 (11) :1264-1269